CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
HBV RNA is a predictive marker for HBeAg loss during antiviral treatment with nucleoside/nucleotide analogues in patients with chronic hepatitis B virus (HBV) infection
DOI 10.1055/s-0032-1323983
Bibliografische Angaben
Nachweis in CareLit
Autor:innenFV Bömmel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Treatment with NUCs can completely suppress HBV DNA levels in most patients, however there are few markers for the prediction of long term response. Circulating HBV mRNA particles can be detected in the serum (Su et al., 2001). We studied the association of treatment response with serum levels of full-length (fl) and truncated (tr)HBV mRNA. Methods: For specific detection and quantification of fl and trRNA spe…
Zitieren
Zitierempfehlung
FV Bömmel (2012) HBV RNA is a predictive marker for HBeAg loss during antiviral treatment with nucleoside/nucleotide analogues in patients with chronic hepatitis B virus (HBV) infection. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0032-1323983
Mit CareLit weiterarbeiten